Example: Heart Attack

Search clinical trials for: Immunoglobulins, Intravenous

Total 1687 results

NCT04503993

Active, not recruiting

Healthy Planet Hepatitis B

Conditions: Hepatitis B
NCT04500067

Recruiting

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Conditions: Covid19; Pneumonia
NCT04495764

Recruiting

Registry of Sustained Immunity to COVID-19 Among ESKD Patients

Conditions: Anti-SARS-CoV-2 and SARS-CoV-2 Infection
NCT04494984

Recruiting

A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Conditions: Covid19
NCT04493060

Not yet recruiting

Niraparib and Dostarlimab for Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8
NCT04483622

Recruiting

Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

Conditions: Covid19
NCT04479267

Recruiting

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Double or Triple Hit Lymphoma

Conditions: Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2 and BCL6 Rearrangements
NCT04480424

Not yet recruiting

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Conditions: COVID-19
NCT04476329

Not yet recruiting

Optimization for Regorafenib in HCC

Conditions: Hepatocellular Carcinoma
NCT04477772

Not yet recruiting

A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China

Conditions: Recurrent/Refractory Malignant Lymphoma
NCT04478084

Not yet recruiting

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Conditions: Rabies (Healthy Volunteers)
NCT04478227

Not yet recruiting

TPO Use in Children for Hemotopoietic Failure

Conditions: Bone Marrow Failure Disorders; Aplastic Anemia; Thrombocytopenia; Refractory Cytopenia of Childhood; Myelodysplastic Syndrome(MDS)
NCT04475523

Not yet recruiting

Phase 1 Study of CI-8993 Anti-VISTA Antibody in Patients With Advanced Solid Tumor Malignancies

Conditions: Solid Tumor
NCT04471038

Recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

Conditions: Influenza Type A; Influenza Type B; Influenza
NCT04468958

Recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

Conditions: COVID-19; SARS-CoV2
NCT04469179

Not yet recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

Conditions: COVID-19; SARS-CoV2
NCT04465760

Not yet recruiting

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis

Conditions: Lymphoma; Malignant Solid Neoplasm; Plasma Cell Myeloma
NCT04466475

Not yet recruiting

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Conditions: CD38 Positive; Plasma Cell Myeloma
NCT04466657

Not yet recruiting

Antioxidant Therapy for COVID-19 Study

Conditions: Covid-19
NCT04464967

Not yet recruiting

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Conditions: Advanced Solid Tumor; Metastatic Cancer; HER2-positive Breast Cancer; HER2-positive Gastric Cancer; HER-2 Protein Overexpression; Esophageal Cancer; Ovarian Cancer; Endometrium Cancer; Bladder Cancer; Pancreatic Cancer; Colorectal Cancer; Non Small Cell Lung Cancer; EGF-R Positive Non-Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Triple Negative Breast Cancer; Cervical Cancer; Sarcoma
NCT04456387

Not yet recruiting

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Conditions: Hemophilia A
NCT04454736

Recruiting

Psychobiological Responses to Choral Singing in Mentally Ill and Healthy Children and Adolescents

Conditions: Stress
NCT04450654

Not yet recruiting

Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)

Conditions: Immune-Mediated Necrotizing Myopathy
NCT04447469

Recruiting

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Conditions: COVID
NCT04447716

Not yet recruiting

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
NCT04447937

Not yet recruiting

Immunodeficiency in MS

Conditions: Multiple Sclerosis; Hypogammaglobulinemia; Immunodeficiency; Infection, Bacterial
NCT04445298

Not yet recruiting

Skin Barrier Assessment in Pregnancy and at Birth

Conditions: Pregnancy Related; Allergy; Atopic Dermatitis Eczema; Asthma in Children; Food Allergy
NCT04441918

Recruiting

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Conditions: COVID-19; and High Infection Risk of SARS-CoV-2
NCT04438603

Recruiting

The Role of T/B Cell Repertoire in Non-invasive Diagnosis and Disease Monitoring in Patients With IgA Nephropathy

Conditions: IgA Nephropathy
NCT04438382

Recruiting

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
NCT04435678

Recruiting

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens

Conditions: Birch Pollen Allergy; Grass Pollen Allergy; House Dust Mite Allergy; Cat Allergy; Bee Venom Allergy; Vespid Venom Allergy
NCT04432324

Not yet recruiting

Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)

Conditions: COVID-19
NCT04434417

Recruiting

Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

Conditions: COVID
NCT04429191

Recruiting

JSP191 Antibody Targeting Conditioning in MDS/AML Patients Undergoing Hematopoietic Cell Transplantation

Conditions: MYELODYSPLASTIC SYNDROME; MDS; ACUTE MYELOID LEUKEMIA; AML
NCT04430452

Not yet recruiting

Hypofractionated Radiotherapy Followed by Durvalumab With or Without Tremelimumab for the Treatment of Liver Cancer After Progression on Prior PD-1 Inhibition

Conditions: Advanced Hepatocellular Carcinoma; Stage III Hepatocellular Carcinoma AJCC v8; Stage IIIA Hepatocellular Carcinoma AJCC v8; Stage IIIB Hepatocellular Carcinoma AJCC v8; Stage IV Hepatocellular Carcinoma AJCC v8; Stage IVA Hepatocellular Carcinoma AJCC v8; Stage IVB Hepatocellular Carcinoma AJCC v8
NCT04428333

Not yet recruiting

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Conditions: Neoplasms, Head and Neck
NCT04423029

Recruiting

Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications

Conditions: Solid Tumor; Melanoma; Renal Cell Carcinoma; Urothelial Carcinoma
NCT04424017

Recruiting

Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

Conditions: COVID; Corona Virus Infection
NCT04418219

Not yet recruiting

A Breast Cancer Vaccine (SV-BR-1-GM) in Combination With Pembrolizumab for the Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Breast Carcinoma; Refractory Breast Carcinoma
NCT04418531

Not yet recruiting

Convalescent Antibodies Infusion in COVID 19 Patients

Conditions: Pneumonia, Viral; Corona Virus Infection
NCT04414969

Recruiting

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Conditions: Immune Checkpoint Inhibitor; Chemotherapy Effect; Epigenetic Disorder; NK/T-cell Lymphoma of Nasal Cavity
NCT04411667

Recruiting

Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection

Conditions: Sars-CoV2
NCT04408963

Not yet recruiting

VRC 611: Human Monoclonal Antibody (mAb) VRC-HIVMAB0102-00-AB (CAP256V2LS)Administered Via Subcutaneous and Intravenous Injection in Healthy Adults

Conditions: HIV
NCT04407247

Recruiting

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Conditions: Colitis; Lung Non-Small Cell Carcinoma; Malignant Genitourinary System Neoplasm; Malignant Solid Neoplasm; Melanoma
NCT04407429

Recruiting

Vienna Versus SARS-CoV-2 Virus Study

Conditions: SARS-CoV-2; COVID-19
NCT04403269

Recruiting

NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE

Conditions: Sars-CoV2
NCT04404088

Recruiting

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Conditions: Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
NCT04400994

Recruiting

IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus

Conditions: Pemphigus
NCT04401085

Completed

COVID-19: Herd Immunity Study in the Czech Republic

Conditions: COVID; SARS-CoV 2
NCT04400058

Recruiting

Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

Conditions: Covid-19

Search clinical trials for: Immunoglobulins, Intravenous

Recent CRA jobs

Scientist - BioAnalytics

Finance Assistant (6 months internship)

Digital Implementation Manager - eCOA (remote)

Sr CM Analyst I

Project Manager - Central Lab

Shipping/ Receiving Coordinator

Associate Scientist / Scientist - GMP , Pilot Plant , Small Molecule

Principal Database Programmer (UK, Spain, Romania, Poland, Ireland)

Global Category Sourcing Manager - Clinical Lab

Clinical Research Physician